897 — Wai Yuen Tong Medicine Holdings Share Price
0.000.00%
Last trade - 00:00- HK$399.41m
- HK$632.60m
- HK$783.88m
- 50
- 65
- 72
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.35 | ||
| Price to Tang. Book | 0.35 | ||
| Price to Free Cashflow | 2.71 | ||
| Price to Sales | 0.92 | ||
| EV to EBITDA | 72,163.67 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.17% | ||
| Return on Equity | -0.38% | ||
| Operating Margin | -6.8% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 620.74 | 1,108.57 | 1,391.41 | 723.6 | 783.88 | n/a | n/a | 0.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Wai Yuen Tong Medicine Holdings Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearl’s and Pearl’s. Property Investment segment is engaged in the investment in commercial properties for rental income.
Directors
- Ching Ho Tang CHM (58)
- Lai Chi Lau CTR
- Man Yee Law EDR (58)
- Wai Man Tang EDR (26)
- Kwok Ho Chiu OTH
- Yin Man Law OTH
- Shuk Fong Wong OTH
- Chung Ho Yuen OTH
- Chin Wa Cheung SEC
- Wing Mou Cho NID (73)
- Wai Ho Leung NID (65)
- Ka Fai Li NID (66)
- Man Ho Siu NID (47)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- August 12th, 1994
- Public Since
- October 31st, 1997
- No. of Employees
- 817
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,125,102,888
- Address
- 5th Floor, Wai Yuen Tong Medicine Bldng
- Web
- https://www.wyth.net/
- Phone
- +852 null23128202
- Auditors
- Ernst & Young LLP
Upcoming Events for 897
Similar to 897
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Wai Yuen Tong Medicine Holdings share price?
As of Today at 24:03 UTC, shares in Wai Yuen Tong Medicine Holdings are trading at HK$0.37. This share price information is delayed by 15 minutes.
How has the Wai Yuen Tong Medicine Holdings share price performed this year?
Shares in Wai Yuen Tong Medicine Holdings last closed at HK$0.37 and the price had moved by +158.19% over the past 365 days. In terms of relative price strength the Wai Yuen Tong Medicine Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +161.13% over the past year.
What are the analyst and broker recommendations for Wai Yuen Tong Medicine Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Wai Yuen Tong Medicine Holdings dividend yield?
The Wai Yuen Tong Medicine Holdings dividend yield is 8.11% based on the trailing twelve month period.
Does Wai Yuen Tong Medicine Holdings pay a dividend?
Last year, Wai Yuen Tong Medicine Holdings paid a total dividend of HK$0.03, and it currently has a trailing dividend yield of 8.11%. We do not have any data on when Wai Yuen Tong Medicine Holdings is to next pay dividends.
When does Wai Yuen Tong Medicine Holdings next pay dividends?
We do not have data on when Wai Yuen Tong Medicine Holdings is to next pay dividends. The historic dividend yield on Wai Yuen Tong Medicine Holdings shares is currently 8.11%.
How do I buy Wai Yuen Tong Medicine Holdings shares?
To buy shares in Wai Yuen Tong Medicine Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Wai Yuen Tong Medicine Holdings?
As of the previous close price of HK$0.37, shares in Wai Yuen Tong Medicine Holdings had a market capitalisation of HK$399.41m.
Where are Wai Yuen Tong Medicine Holdings shares listed?
Here are the trading details for Wai Yuen Tong Medicine Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 897
What kind of share is Wai Yuen Tong Medicine Holdings?
Based on an overall assessment of its quality, value and momentum Wai Yuen Tong Medicine Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Wai Yuen Tong Medicine Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Wai Yuen Tong Medicine Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wai Yuen Tong Medicine Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +92.19%.
As of the last closing price of HK$0.37, shares in Wai Yuen Tong Medicine Holdings were trading +42.04% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Wai Yuen Tong Medicine Holdings PE Ratio?
The Wai Yuen Tong Medicine Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Wai Yuen Tong Medicine Holdings?
Wai Yuen Tong Medicine Holdings' management team is headed by:
- Ching Ho Tang - CHM
- Lai Chi Lau - CTR
- Man Yee Law - EDR
- Wai Man Tang - EDR
- Kwok Ho Chiu - OTH
- Yin Man Law - OTH
- Shuk Fong Wong - OTH
- Chung Ho Yuen - OTH
- Chin Wa Cheung - SEC
- Wing Mou Cho - NID
- Wai Ho Leung - NID
- Ka Fai Li - NID
- Man Ho Siu - NID